Silvant Capital Management LLC trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 11.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,782 shares of the company’s stock after selling 740 shares during the quarter. Silvant Capital Management LLC’s holdings in HCA Healthcare were worth $2,350,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently modified their holdings of the stock. Bangor Savings Bank increased its stake in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares in the last quarter. MFA Wealth Advisors LLC bought a new position in shares of HCA Healthcare in the second quarter worth $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at $28,000. GPS Wealth Strategies Group LLC grew its holdings in HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. bought a new position in shares of HCA Healthcare in the second quarter valued at approximately $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
Analyst Ratings Changes
HCA has been the subject of several analyst reports. Royal Bank of Canada raised their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Morgan Stanley started coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. KeyCorp lowered their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Finally, Leerink Partners raised their price target on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $379.11.
Insider Activity at HCA Healthcare
In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.60% of the stock is currently owned by company insiders.
HCA Healthcare Price Performance
Shares of HCA Healthcare stock opened at $357.19 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The company’s fifty day simple moving average is $392.99 and its two-hundred day simple moving average is $354.17. The firm has a market cap of $92.18 billion, a PE ratio of 16.04, a price-to-earnings-growth ratio of 1.38 and a beta of 1.67. HCA Healthcare, Inc. has a 12-month low of $225.32 and a 12-month high of $417.14.
HCA Healthcare Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.74%. HCA Healthcare’s dividend payout ratio is currently 11.85%.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- Compound Interest and Why It Matters When Investing
- Battle of the Retailers: Who Comes Out on Top?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Insider Buying Explained: What Investors Need to Know
- MarketBeat Week in Review – 10/28 – 11/1
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.